Literature DB >> 15257403

[Leukocytoclastic vasculitis].

C Sunderkötter1, J Roth, G Bonsmann.   

Abstract

Leukocytoclastic vasculitis (LcV) is the most common form of cutaneous vasculitis. Often LcV results from deposition of immune complexes in the vascular wall. When IgA is the dominant immunoglobulin in these complexes, systemic involvement is likely (Henoch-Schönlein purpura), being more severe in adults. LcV in which immune complexes are composed of IgG or IgM are more often limited to the skin and may additionally show minor systemic involvement. In other forms of LcV additional pathophysiological factors play a role. LcV can also be a presenting or accompanying symptom of severe systemic ANCA-associated vasculitis. In some cases, LcV is a sign of bacteriemia. The aim of diagnostic procedures is to determine the specific type of vasculitis and degree of systemic involvement as well as possible causes. If no trigger or cause can be found, uncomplicated cases of LcV should be treated symptomatically. Corticosteroids are indicated at initial signs of necrosis or ulceration. Chronic recurrent LcV may respond to dapsone or colchicine. Severe systemic vasculitis requires immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257403     DOI: 10.1007/s00105-004-0760-1

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  48 in total

1.  Acute infantile hemorrhagic edema and Henoch-Schönlein purpura: is IgA the missing link?

Authors:  Jatinder S Goraya; Sukhjot Kaur
Journal:  J Am Acad Dermatol       Date:  2002-11       Impact factor: 11.527

Review 2.  Complement and immune complexes.

Authors:  J A Schifferli
Journal:  Res Immunol       Date:  1996-02

Review 3.  The role of complement and its receptor in the elimination of immune complexes.

Authors:  J A Schifferli; Y C Ng; D K Peters
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

Review 4.  Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature.

Authors:  F T Saulsbury
Journal:  Medicine (Baltimore)       Date:  1999-11       Impact factor: 1.889

5.  Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome.

Authors:  R Blanco; V M Martínez-Taboada; V Rodríguez-Valverde; M García-Fuentes; M A González-Gay
Journal:  Arthritis Rheum       Date:  1997-05

Review 6.  Urticarial vasculitis: a histopathologic and clinical review of 72 cases.

Authors:  D R Mehregan; M J Hall; L E Gibson
Journal:  J Am Acad Dermatol       Date:  1992-03       Impact factor: 11.527

7.  Parvovirus B19 associated adult Henoch Schönlein purpura.

Authors:  Adina M Cioc; Daniel D Sedmak; Gerard J Nuovo; Magdy R Dawood; Gerry Smart; Cynthia M Magro
Journal:  J Cutan Pathol       Date:  2002-11       Impact factor: 1.587

8.  Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study.

Authors:  S J Jessop
Journal:  Br J Rheumatol       Date:  1995-10

9.  Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate and IgG paraproteinaemia: a variant of Schnitzler's syndrome?

Authors:  D Nashan; C Sunderkötter; G Bonsmann; T Luger; S Goerdt
Journal:  Br J Dermatol       Date:  1995-07       Impact factor: 9.302

10.  Efficacy and safety of rituximab in type II mixed cryoglobulinemia.

Authors:  Francesco Zaja; Salvatore De Vita; Cesare Mazzaro; Stefania Sacco; Daniela Damiani; Ginevra De Marchi; Angela Michelutti; Michele Baccarani; Renato Fanin; Gianfranco Ferraccioli
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

View more
  5 in total

1.  [Cutaneous lupus erythematosus. Part 1: clinical manifestations and classification].

Authors:  A Kuhn; K Gensch; S Ständer; G Bonsmann
Journal:  Hautarzt       Date:  2006-03       Impact factor: 0.751

Review 2.  [Skin manifestations of different forms of vasculitis].

Authors:  C Sunderkötter
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

Review 3.  [Cutaneous vasculitides. A diagnostic approach].

Authors:  K Schäkel; M Meurer
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

Review 4.  [Histology of cutaneous vasculitides].

Authors:  A Stein; I Hackert; M Meurer
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

Review 5.  [Therapy of vasculitides and vasculopathies].

Authors:  C Sunderkötter; K de Groot
Journal:  Hautarzt       Date:  2008-05       Impact factor: 0.751

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.